Skip to main content
A

Apt Medical Inc. — Investor Relations & Filings

Ticker · 688617 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 6 across all filing types
Latest filing 2026-04-14 Declaration of Voting R…
Country CN China
Listing Shanghai Stock Exchange 688617

About Apt Medical Inc.

Apt Medical Inc. is a specialized developer and manufacturer of advanced medical devices for minimally invasive vascular interventions. The company focuses on the fields of electrophysiology, interventional cardiology, and peripheral vascular procedures. Its product portfolio includes diagnostic and ablation catheters, steerable sheaths, guide wires, microcatheters, and balloon catheters designed for complex cardiovascular treatments. Apt Medical emphasizes research and development to provide high-precision tools for clinicians, aiming to improve procedural outcomes in the treatment of cardiac arrhythmias and vascular diseases. The company serves a global market, providing integrated solutions for interventional procedures through a commitment to technological innovation and quality manufacturing standards.

Recent filings

Filing Released Lang Actions
2025年年度股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is a formal announcement of the 2025 Annual Shareholders’ Meeting resolutions, detailing each agenda item and its vote counts and percentages. It reports the results of shareholder voting, specifying the number of votes for, against, and abstentions, and summarizes meeting attendance and legal compliance. This matches the definition for Declaration of Voting Results & Voting Rights Announcements (DVA).
2026-04-14 Chinese
第三届董事会第五次会议决议公告
Regulatory Filings Classification · 1% confidence The document is a public announcement of the board of directors’ resolution at the third board meeting of Shenzhen Huitai Medical. It contains no executive changes (so not MANG), no shareholder vote results (DVA is for AGMs/EGMs), no financial report, no proxy materials, no dividend, no M&A, etc. It is a regulatory announcement of a board resolution approving the initial grant of restricted shares. Since there is no more specific category, it falls into the general Regulatory Filings category (RNS).
2026-04-14 Chinese
2026年限制性股票激励计划首次授予激励对象名单（首次授予日）
Share Issue/Capital Change Classification · 1% confidence The document is a formal announcement by Shenzhen Huitai Medical Devices Co., Ltd. detailing the first grant of restricted stock under its 2026 equity incentive plan, including allocations and proportions for directors, senior management, and other participants. It specifies the total number of shares to be issued and reserved under the plan. This constitutes a notification of new share issuance under an employee incentive program, which falls under the category “Share Issue/Capital Change” rather than a buyback or financing update. Therefore, the appropriate classification is SHA.
2026-04-14 Chinese
董事会薪酬与考核委员会关于公司2026年限制性股票激励计划首次授予激励对象名单（首次授予日）的核查意见
Remuneration Information Classification · 1% confidence The document is issued by the Board’s Remuneration and Assessment Committee, providing verification opinions on the first grant list under the 2026 restricted stock incentive plan. It cites relevant laws and rules governing equity incentives and confirms the grant details (number of shares, price, date). This directly pertains to executive/director compensation arrangements, fitting the Remuneration Information category (DEF 14A).
2026-04-14 Chinese
关于2026年限制性股票激励计划内幕信息知情人买卖公司股票情况的自查报告
Regulatory Filings Classification · 1% confidence The document is a self-inspection report about insider persons’ stock trading behaviors in relation to the company’s 2026 restricted stock incentive plan, disclosing that no improper insider trading occurred. It is a regulatory disclosure required by securities rules rather than a financial report, earnings release, share issuance, or insider director trade notice. It does not announce a report’s publication nor fit other specific categories, making it a miscellaneous regulatory filing. Therefore, it falls under Regulatory Filings (RNS).
2026-04-14 Chinese
北京市嘉源律师事务所关于深圳惠泰医疗器械股份有限公司2025年年度股东会的法律意见书
AGM Information Classification · 1% confidence The document is a legal opinion letter issued by a law firm on the 2025 annual shareholders’ meeting (AGM) of Shenzhen Huitai Medical Devices Co., Ltd. It is part of the materials produced for and shared in connection with the AGM rather than a vote-result announcement or proxy solicitation statement. Therefore it best fits under AGM Information (AGM-R).
2026-04-14 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.